The news that President Trump and the first lady, Melania Trump, have tested positive for the coronavirus has raised the question of whether they will be treated with experimental drugs for Covid-19.
There are no approved treatments for Covid-19, but two of the most promising candidates, antibody treatments developed by Eli Lilly and Regeneron, are being tested in patients around the country. Initial results have suggested that they can reduce the level of the virus in the body and possibly shorten hospital stays — when they are given early in the course of infection.
A spokeswoman for Eli Lilly declined to comment on Friday about whether the company had been contacted about providing a treatment to Mr. Trump. “Thanks for your question,” the spokeswoman, Molly McCully, said in an email. “However, we cannot answer it.” She did not immediately comment on whether the company has already provided its coronavirus treatment to people who are not participating in its trials.
A spokeswoman for Regeneron, Hala Mirza, said the company doesn’t “identify individuals who have or have not submitted a request or who are participating in our clinical trials without their consent.”